Sky Century Investment (SKYI) Interest Expenses (2024 - 2025)

Sky Century Investment's (SKYI) quarterly Interest Expenses came in at $186246.0 in Q2 2025, up 1.49% on a QoQ basis from $183506.0 in Q1 2025.

Sky Century Investment (SKYI) Interest Expenses (2024 - 2025) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Interest Expenses data on file, last reported at $186246.0 in Q2 2025.

On a quarterly basis, Interest Expenses changed N/A year-over-year to $186246.0 in Q2 2025; TTM through Feb 2026 was $513.0, a 99.72% decrease from a year earlier, with the FY2025 full-year figure at $193765.0, up 14.55% from the prior year.
Interest Expenses for Q2 2025 stood at $186246.0, up from $183506.0 in the prior quarter.
Over the last five years, Interest Expenses for SKYI reached as high as $186246.0 in Q2 2025 and fell as low as $513.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Expense (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	62.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	944.51 Mn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	1.77 Bn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	2.17 Bn
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	1.21 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	590.20 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	57.00 Mn
10	Sky Century Investment	1.06 Mn	1.06 Mn	26,045.00	-

Download Data